Links

Professional fees in PE–owned gastroenterology practices.The Anthropic Economic Index (full paper).Physician tenure and clinical productivity.‘Ineffective’ generic drugs fuel rare public anger in ChinaSupport cancer survivors (Randy Moss edition)

Read More

The Nurse as Designer: Breaking Down Barriers with Clinician-Center Innovation

Integrating nursing expertise into technology design, development, and implementation fosters early user support, establishes credibility with the technology, and leads to significantly better usage across the organization, avoiding the creation of process workarounds. The post The Nurse as Designer: Breaking Down Barriers with Clinician-Center Innovation appeared first on MedCity News.

Read More

Who is Speaking at INVEST 2025?

The healthcare investor conference, scheduled for May 20 and 21 at the Willis Tower in Chicago, combines panel discussions, networking opportunities, and a startup pitch contest. Register today! The post Who is Speaking at INVEST 2025? appeared first on MedCity News.

Read More

Guillain-Barre Syndrome (GBS) Spread

What is Guillain-Barre Syndrome (GBS)? Guillain-Barre Syndrome (GBS) is a rare but serious autoimmune disorder in which the body’s immune system mistakenly attacks the peripheral nervous system. It can cause muscle weakness, numbness, tingling, and even paralysis in severe cases. Although most patients recover, it can be life-threatening if the breathing muscles or autonomic functions…

Read More

George Boghos, Imagine Pediatrics

George Boghos is CEO of Imagine Pediatrics, a company founded out of former CMS Innovation head Adam Boehler’s Rubicon Partners fund. Imagine is a wraparound tech-based service helping some of the sickest kids in America–think kids on feeding tubes, cancer, mental health conditions, autism and more. They provide telehealth and on the ground services (like…

Read More

Public vs. Private Sector R&D Investments

In 2011, National Institutes of Health (NIH)-funded discoveries contributed $69 billion to the nation’s gross domestic product (GDP) and supported seven million jobs. In 2020 alone, the US biomedical and pharmaceutical private sector generated more than $1.4 trillion in economic output. From Reece et al. (Health Affairs 2025) In addition to economic output, private-sector R&D…

Read More